Adenia Partners Acquires Majority Stake in Parkville Pharmaceuticals

CapVest Acquires Majority Stake in STADA Arzneimittel

September 1, 2025

Healthcare Services

CapVest Partners LLP has completed its acquisition of a majority stake in STADA Arzneimittel AG, a global healthcare and pharmaceuticals company focused on consumer healthcare, generics, and specialty pharmaceuticals. CapVest and STADA plan to accelerate STADA’s global growth through both organic initiatives and strategic acquisitions.

PAI Partners Acquires 67% Stake in VAMED's European Rehabilitation Business from Fresenius

May 2, 2024

Healthcare Services

PAI Partners will acquire a 67% stake in VAMED's pan‑European rehabilitation business from Fresenius, with Fresenius retaining a 33% stake. The carved‑out business operates 67 clinics across multiple European countries, employs around 10,000 staff and will operate as a standalone rehabilitation platform focused on operational excellence and further investment.

Warburg Pincus and Mubadala Acquire Pharma Intelligence from Informa

June 1, 2022

Data & Analytics

Warburg Pincus, joined by Mubadala Investment Company, completed the acquisition of Pharma Intelligence (the Citeline suite and related specialist brands) from Informa PLC, with Informa retaining a 15% equity stake. The investors said they will invest in product development and innovation to expand Pharma Intelligence's position in the pharmaceutical data and analytics market; Jay Nadler was appointed Executive Chair following completion.

Advent International to Acquire Significant Stake in Suven Pharmaceuticals

December 26, 2022

Pharmaceuticals

Advent International has entered into a definitive agreement to acquire a significant stake in Suven Pharmaceuticals from the Jasti family and will make an open offer for an additional 26% of public shares. Advent plans to evaluate a merger of its CDMO and API platform company, Cohance Lifesciences, with Suven to create a scaled end-to-end CDMO + merchant API powerhouse serving pharma and specialty chemical markets, subject to board and regulatory approvals.

Avista Healthcare Partners Acquires PK Benelux

November 20, 2025

Healthcare Services

Avista Healthcare Partners completed its acquisition of PK Benelux, a leading Netherlands-based vitamins, minerals, and supplements (VMS) company known for the Lucovitaal brand. The deal strengthens Avista’s consumer health platform and supports continued growth in the Netherlands and broader Western European markets.

Olympus Partners Acquires PAI Pharma

February 24, 2025

Pharmaceuticals

Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.